
5 ‘Fallacies' Narcissists Use To Confuse And Control You — By A Psychologist
Narcissists rely on these five 'logical fallacies' like a crutch. But, with a little bit of probing, ... More their arguments ultimately fall flat.
Narcissists may come across as confident and convincing during arguments. But as soon as you peel back the surface layers of their reasoning, it begins to lose its integrity. That's because, as research shows, narcissists aren't interested in understanding opposing perspectives. They only care about winning.
A 2023 study from Frontiers in Psychology found that narcissists tend to score low in intellectual humility. In other words, they're quick to assume they're right — and just as quick to reject any and all evidence that challenges them. Instead of engaging in good-faith dialogue, they usually resort to manipulative tactics that prop up their ego and snuff dissent.
Beyond protecting the narcissist's self-image, these tactics also serve to exploit their victims' vulnerability. As a 2024 study in Memory & Cognition explains, people are more likely to accept weak or poorly reasoned arguments if those arguments align with what they already believe or fear.
Narcissists leverage this cognitive bias by framing their arguments in emotionally loaded ways: they reinforce your insecurities by twisting the logic just enough to make you second-guess yourself. This allows them to arm themselves with a suite of flawed but familiar tactics; each is designed to confuse, derail and dominate both you and the conversation.
In a previous article, I covered five of the most common fallacies that narcissists rely on. In this follow-up, I'll explore five more tactics they keep in their arsenal — and how they use them to stay in control.
A causal fallacy occurs when someone mistakenly assumes there to be a cause-and-effect relationship between two events. This can be achieved in various ways: by oversimplifying an obviously complex situation, by falsely attributing blame to a victim or simply by jumping to conclusions without any evidence.
These fallacies are especially dangerous in confrontations, as they serve to manipulatively distort the victim's sense of reality.
For instance, a narcissist might claim, 'You made me yell at you by stressing me out.' Here, they imply that their anger was a direct result of the victim's actions. In one sentence, the aggressor suggests the victim is responsible for their behavior, while simultaneously ignoring the fact they chose to react aggressively.
Narcissists employ causal fallacies as a means to shift blame onto their victims, all while avoiding accountability for their actions. They represent their behavior as an inevitable reaction to something external; in turn, they spin a narrative in which the victim is the one at fault.
Unlike many of the other fallacies, the burden of proof fallacy doesn't serve to conjure up false narratives, nor to ignore or refute the points that have been made. Instead, it occurs when someone shifts the responsibility of proving a claim onto the person who initially made it.
Yet, in great similarity to the other fallacies, this tactic also serves to evade accountability. Specifically, because it demands an unreasonable — or even impossible — level of evidence from the accuser.
For instance, if a victim says, 'You've been lying to me,' the narcissist would simply respond with, 'Well, then prove it.' Even if there's very clear circumstantial evidence to support the claim, they refuse to acknowledge wrongdoing. That is, unless the victim provides absolute, irrefutable proof, which makes it all the more difficult to hold them accountable.
Narcissists rely on the burden of proof when they are acutely aware of how challenging it will be for their victim to distinctly or undeniably evince their deception or manipulation. Naturally, deferring this responsibility sets an incredibly unfair standard: it makes it nearly impossible for their victim to gain closure or defend their dignity.
The appeal to nature fallacy erroneously assumes that something is good, right or acceptable simply by claiming that it's 'natural.' Despite how persuasive these arguments may sound, it's important to note that this reasoning completely ignores whatever ethical concerns surround the behaviors.
The appeal to nature oversimplifies objectively harmful human behaviors; by attributing these behaviors to biology or tradition — rather than personal choice — the victim is falsely led to believe that they're impossible to condemn.
For instance, a male narcissist might justify their aggression by saying, 'Men are just naturally dominant. You should accept it.' Or, on the other hand, a female narcissist might say, 'Women are naturally overprotective. You can't blame me for that.'
Arguments like these suggest that harmful behaviors, such as control or possessiveness, are merely unavoidable. But, in reality, these behaviors are always a conscious decision — ones that can and should be challenged and changed.
Narcissists appeal to nature purely so that they can normalize their unacceptable or abusive behaviors. They frame their actions as either natural or inevitable, and, as a result, they render any meaningful discussion regarding boundaries futile.
More insidiously, these appeals make their victim feel unreasonable for expecting a different or better relationship with the aggressor. Cyclically, this reinforces control by making it seem as though the victim is resisting something fundamental, rather than rightly rejecting their mistreatment.
The appeal to ignorance fallacy is, in many ways, quite similar to the burden of proof. However, it rests on a different, faulty (yet equally cunning) assumption: that a lack of evidence against something automatically makes it true. Or, conversely, that a lack of evidence for something automatically makes it false. In reality, absence of evidence is not evidence of absence.
When narcissists use this fallacy, they exploit uncertainty by twisting it into certainty. For instance, if someone says, 'You've been acting strangely lately, and I get the feeling that you're hiding something from me.' In turn, a narcissist might respond with, 'If you can't prove I've done anything wrong, then I haven't.'
Unlike the burden of proof — which pressures others to produce impossible evidence — the appeal to ignorance shuts down the conversation by pretending that not having definitive proof is the same thing as being exonerated. It reframes ambiguity as innocence, which urges the victim to discount their own judgment.
This tactic is especially effective in emotionally complex situations. If intuition, patterns or past behavior may point to wrongdoing, but hard proof is hard to come by, narcissists lean on this fallacy to rewrite the narrative in their favor.
The appeal to personal incredulity fallacy serves to dismiss something as false simply because it sounds unbelievable or difficult to understand. This reasoning invalidly relies on gut reactions, rather than any hard facts. Consequently, it allows aggressors to reject evidence of their wrongdoings — purely because they don't like or can't comprehend it.
Say, for instance, a narcissist is presented with evidence of their manipulation tactics. In response, they might say something like, 'That's ridiculous! I would never do that.' Here, they reject reality simply because they don't want to acknowledge it. As opposed to taking the time to disprove the claim or apologize, they merely dismiss it outright as being absurd.
Narcissists often rely on personal incredulity fallacies, as it allows them to shut down conversations without expending any effort whatsoever. They simply act as though an idea is too far-fetched to even consider, which makes it nearly impossible to challenge.
In turn, it's futile for the victim to attempt to discuss their behavior in any meaningful way. And, even if they do, they'll more than likely tire themselves out by over-explaining their concerns.
Concerned that you might have narcissistic tendencies? Take this science-backed test to find out if it's cause for concern: Narcissism Scale
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Associated Press
22 minutes ago
- Associated Press
New online tool helps women on Medicaid find prenatal care and family planning
At the University of Mississippi Medical Center, one researcher's full-time job for the past nine months has been to find out which clinics around the state offer different kinds of women's health care, and whether they accept various forms of Medicaid. The final result is a recently launched database aimed at helping women locate the nearest clinic that can offer the care they need. The work that went into creating it highlights a pervasive problem: Even making an appointment can be a barrier that keeps women from improving their lives. 'We Need to Talk' is a compilation of all Mississippi clinics offering prenatal care – specifying which ones also offer family planning, and whether they take Medicaid insurance, Medicaid waivers and see women whose Medicaid applications are pending. There is also a hotline designed to give additional support to anyone having questions or feeling overwhelmed about the process. 'Having gone through the work, it was remarkable. It wasn't easy to figure out where you should go for care,' said Dr. Thomas Dobbs, former state health officer and dean of the John D. Bower School of Population Health at UMMC, who oversaw the project. 'And that should be one of the most basic bits of information we have.' The idea was born from the recent 900% increase in babies born with syphilis, Dobbs explained, which he called a 'canary in a coal mine' signaling more danger to come. An investigation into the epidemic showed that one of the driving factors was delayed prenatal care, caused in large part by inaccessible information and concerns about cost, Dobbs said. Finding reproductive and prenatal care can be difficult for several reasons. For one thing, there are many different kinds of clinics in Mississippi, making it hard for patients to know what to search for. The list includes federally qualified health centers, county health department clinics and private OB-GYNs. Another reason is that many clinics don't specify online whether they take Medicaid, much less what their policy is on specific or temporary Medicaid coverage. Calling doesn't always guarantee patients a comprehensive or accurate answer. The new database is an initiative of UMMC's Myrlie Evers-Williams Institute – housed in the Jackson Medical Mall – which is committed to eliminating health disparities by studying the intersection of health and social issues. The institute has a clinic on site that practices what's called 'social medicine,' a key element of eliminating those disparities, the institute's executive director Victoria Gholar explained. 'If you have a patient who has asthma and they're living in a situation where mold is in their environment, it will really be hard for them to get better,' Gholar said. 'Or, if we have a patient who has to use an electronic (medical) device, and their electricity is no longer available because they weren't able to take care of their utility bill, then we try to work with them and connect them to resources that might be able to help.' The institute employs a wide range of professionals who work on health from a non-clinical standpoint, such as researchers, community engagers, social workers and registered dietitians. It hosts events like food drives and offers free support from budgeting strategies to meal preparation for those with conditions like diabetes or high blood pressure. Aside from knowing what to search for, finding clinics that accept Medicaid can also be complicated because Mississippi Medicaid eligibility is constantly changing for a woman based on her age and circumstance – what kinds of services she's seeking, as well as whether she's pregnant. Medicaid eligibility in Mississippi is among the strictest in the nation, with one exception – pregnant women. That means many low-income women only become eligible for Medicaid once pregnant. And since an application can take up to eight weeks to be processed, the chances that a woman in this situation will be able to use her newly acquired Medicaid insurance in the first trimester are slim. A law that would cut out this interim period and allow low-income pregnant women to be immediately seen by a doctor passed the Legislature in 2024, but was never implemented because of legislative errors. The policy went back through the Legislature in 2025, passed overwhelmingly again, but is not yet in effect. Some doctors already see women whose Medicaid application is pending, and the UMMC tool specifies at which clinics that's the case. Women of reproductive age seeking reproductive health care are also eligible for leniency in the typical Medicaid stipulations. These women can apply for a Medicaid family planning waiver, which allows them to access Medicaid for family planning purposes, even if they don't qualify for general Medicaid coverage. The income requirement for pregnancy Medicaid and the family planning waiver is a household income of less than 194% of the federal poverty level, or about $2,500 a month for one person in 2025. Dobbs, who has been the main point person on the project, said he hopes the online database is one more resource improving health care accessibility and women's health metrics in Mississippi. 'This isn't about getting patients to UMMC at all,' Dobbs said. 'It's about empowering patients to be able to get the care they need where they live.' ___ This story was originally published by Mississippi Today and distributed through a partnership with The Associated Press.


Medscape
28 minutes ago
- Medscape
A PCP Guide to Emerging Therapies for Resistant Hypertension
This transcript has been edited for clarity. Matthew F. Watto, MD: Welcome back to The Curbsiders . I'm Dr Matthew Frank Watto, here with my great friend and America's primary care physician, Dr Paul Nelson Williams. Paul, this is a topic you know a ton about, isn't it? Paul N. Williams, MD: It's one I always have questions about; I think this is our 37th episode on high blood pressure, if I'm not mistaken. Watto: The audience can't get enough of it — turns out, neither can I. Williams: Me neither! Watto: I love talking about high blood pressure, and this was with a great guest, Dr Jordy Cohen. She's a hypertension expert and a nephrologist. Paul, to start us off, what are we doing with blood pressure cuffs these days? Those manual ones on the wall, those are the way to go, right? Williams: This is a scenario we talk about all the time, and we've beat this drum a lot in prior episodes. I think we've all experienced a patient whose initial triage blood pressure reading is elevated, and either you or the patient will ask for a recheck and you're tempted to use a blood pressure cuff that's been hanging on the wall, has not been calibrated in 17 years, has a decaying spiral cord, and looks like it would fall apart if you touched it. Turns out that's probably not the best way to do it, Matt. So, to reiterate: Automated cuffs are the preferred option. They are more accurate. In this episode with Dr Cohen, we talked about making sure we use the appropriate cuff size and when we have patients who have large arms, you may have to use a wrist measurement every so often. In these circumstances, positioning matters: feet flat, back supported, elbow resting on a table, and have two fingers on the opposite clavicle so that everything is at heart level. If you're taking the blood pressure reading using a cuff around the arm itself, again, you should make sure the patient's arm is resting on a tabletop, bedside, or even on your own arm to ensure it's at heart level. You also shouldn't talk with the patient during that process so you can give them every chance to have an accurate blood pressure reading. That's the first thing: Get an accurate reading. Then everything else follows that step, as you should only treat a diagnosis that you've appropriately made. Watto: All the goals are based on a properly taken blood pressure, so if your patient's blood pressure hasn't been appropriately measured, you might overtreat or undertreat someone. For most patients who are nonfrail, we're now shooting for a blood pressure that is below 130/80 mm Hg. The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines for patients with chronic kidney disease state that normal blood pressure should be below 120/80, which is very hard to do. If we're getting people with a systolic in the 120s, that's probably about as good as we're going to get. For treatment, Dr Cohen and I have adopted this practice of using combination pills for hypertension management — either a calcium-channel blocker with an angiotensin-converting enzyme inhibitor or an angiotensin II receptor blocker (ARB). I usually prefer a calcium-channel blocker with an ARB or the 'triple pill,' a single-pill combination of a calcium-channel blocker, an ARB, and a diuretic. That's what I go to now as my first-line agent. I'm using a lot of either low-dose or medium-dose combination therapy. I don't usually go to the highest dose unless I'm in a situation where I have to decide between starting a fourth medication or going to a higher dose. That's really been a practice change for me. Dr Cohen reiterated that point and emphasized that it's easiest for the patient and they usually experience fewer side effects when you choose a low-to-moderate dose in comparison to a high dose. Williams: It's a point that we've made in prior episodes, as well. As you start to max out the doses of these medications, you get diminishing returns in terms of their efficacy in lowering blood pressure efficacy and patients can start to experience increased side effects. It's a far better option to start with a kind of median dose as opposed to really trying to crank up the dose, because you just don't get that much more benefit with that approach. Watto: We're going to discuss some of the newer blood pressure–lowering agents. Paul, the first one I want to ask you about is not quite a blood pressure medication, but it does lower blood pressure. Which medication am I talking about here? Williams: I think you're probably referring to semaglutide, Matt. I think we all have a fair amount of comfort with these diabetes and weight loss medications. These are remarkable medications and the indications keep piling on, which is great. Semaglutide, in particular, is not approved for hypertension, but it does lower blood pressure, likely as a result of the weight loss that is achieved with the medication. So, it's not technically an antihypertensive, but it provides a great blood pressure benefit. I think there's also some 'fancy pants' medications coming down the pipeline that we should probably be aware of, right? Watto: Yes, and the first one I'll mention is endothelin receptor antagonists. As a generalist, you're probably not going to be prescribing these; they will probably be prescribed by a hypertension specialist. Compared with placebo, they have a modest effect in lowering blood pressure (~4 mm Hg), but they are officially approved, so they're out there. What's more exciting, Paul, are aldosterone synthase inhibitors. The generic names for these include baxdrostat and lorundrostat. They're not yet approved, but I believe they are in phase 2 or phase 3 trials, depending on the indications. They seem promising, as they have a much stronger effect on blood pressure (~10-15 mm Hg) compared with placebo. Dr Cohen thinks these medications are probably going to be in the primary care wheelhouse soon. Cost will probably an issue with these medications at the start, but otherwise, these are pills that are taken once a day and they don't have the antiandrogen side effects that you can get with the mineralocorticoid receptor antagonists (MRAs), like spironolactone. Dr Cohen was really excited about being able to prescribe these at some point. Williams: And the MRAs are traditionally a fourth-line medication (unless you have compelling indications), so to have something else in your armamentarium that has less side effects is super exciting. It'll be great to see these in the pipeline. Watto: Now, what would you say, Paul, if I told you there was a medication for blood pressure that is only administered once every 6 months and will shut down the renin-angiotensin-aldosterone system (RAAS)? How does that sound? Williams: As someone who's taken medical school physiology, it sounds lightly terrifying! It feels like you do need the RAAS for some things, but I think for patients that are less interested in taking medications — which turns out to be most patients — it could potentially be exciting. I think as long as we have a way to reverse the effects of this medication if needed, then I think there's potential for excitement around this medication. Watto: I'm of course talking about a small interfering RNA (siRNA) agent. The one we talked about in this episode was zilebesiran; it's an siRNA agent and is administered once every 6 months. But no one would feel comfortable giving this unless there's an antidote, because if a patient gets septic, they probably need their RAAS to help them out there. Williams: Or if you have a patient who is pregnant — lots of reasons why you might actually want that system working. Watto: Exactly. Now, some people just don't want to take medications even if they need them, Paul. What else might be offered to a patient with high blood pressure? And how excited should we be about this next therapy? Williams: I feel like you're asking the wrong guy, Matt! I think you're alluding to renal denervation therapy. I feel it had a lot of wild enthusiasm initially, then it kind of waned, and now I feel like enthusiasm is back, baby — we're back into renal denervation. It sounds like a great option and I think we're doing a little better job with it, but its effect on lowering blood pressure is about equivalent to the effect you observe with a single-agent medication. So, realistically, these patients may still need to be on medications for blood pressure control. It's only effective for about two thirds of patients who get the procedure; that's 33% of your patients who would go through this invasive procedure where we're frying a nerve and in the end, they may not actually experience any blood pressure benefit. I think there's still a population that would benefit from and be interested in this option, but I don't think it's something that we should consider as first-line therapy for the majority of folks because of that potential for treatment failure and the continued need for medications among a substantial portion of the patients who undergo this procedure. It's still exciting that there's evidence for it and it does cause significant blood pressure lowering, so it's nice to have another option. Watto: Yeah, and I think patients are going be coming in and asking about it, so having some knowledge about the pros and cons of the procedure is important.


New York Times
28 minutes ago
- New York Times
Palantir's Collection of Disease Data at C.D.C. Stirs Privacy Concerns
The Centers for Disease Control and Prevention's plans to consolidate data on diseases like measles and polio are raising concerns about patient privacy, delays in spotting long-term trends and ways the Trump administration may use the information. The agency told state officials earlier this week that it would shift disease information to a new system managed by Palantir, the data analysis and technology firm co-founded by Peter Thiel. The change is not entirely unexpected. The Covid pandemic revealed that the C.D.C.'s data systems were antiquated, hobbling the country's response in the crucial early months. A plan to modernize and consolidate the agency's data systems began during the Biden administration. But news that the Trump administration has expanded Palantir's work across the federal government in recent months, allowing it to compile detailed information about Americans, has introduced a new layer of anxiety and mistrust among state and local officials about sharing data with the C.D.C. Palantir's systems, including those at the C.D.C., rely on a platform called Foundry that could merge information from different agencies. The Department of Health and Human Services, the Food and Drug Administration and the National Institutes of Health all use Foundry. Some officials worry that a sprawling data collection system could expose or endanger people with sensitive health needs, like gender care, reproductive health care or disabilities. Some labor and other advocacy groups have tried to block the Trump administration from sharing data across agencies. Want all of The Times? Subscribe.